A Randomized Phase II Study Of CMF Alone And In Combination With Anti c-erbB2 Antibody (Herceptin) In Women With c-erbB2 Positive Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Trastuzumab (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Feb 2010 Planned number of patients changed from 66 to 90 as reported by Roche record.
- 17 Oct 2009 Status changed from active, no longer recruiting to completed as reported by Roche record.